|
|
Article: Bradley Pharmaceuticals Announces Acquisition of International Product Portfolio and Settlement of Litigation.
- Article from:
- PR Newswire
- Article date:
- July 1, 2004
CopyrightCOPYRIGHT 2004 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Bradley Pharmaceuticals, Inc. announced today that it has entered an agreement with Dermik Laboratories, a division of Aventis Pharmaceuticals Inc., to acquire exclusive distribution and marketing rights in selected international markets to the prescription acne and rosacea products Benzamycin(R), Klaron(R) and Noritate(R) and three additional products, Hytone, Sulfacet R and Zetar Shampoo.
Pursuant to this agreement, Bradley will have exclusive distribution and marketing rights to these products for eight years in Australia, Japan and the countries comprising the former Soviet Union, Saudi Arabia, the United Arab Emirates, Kuwait and Egypt in the Middle East, ...